No Data
Founder of Celldex Therapeutics Anthony Marucci Buys 40% More Shares
Celldex Therapeutics to Present at Upcoming Investor Conferences
Celldex Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Cantor Fitzgerald Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $67
TD Cowen Maintains Celldex Therapeutics(CLDX.US) With Buy Rating
A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $44 to $80